Last updated: July 10, 2025
Sponsor: University Hospital of Ferrara
Overall Status: Active - Not Recruiting
Phase
N/A
Condition
Mitral Valve Regurgitation
Heart Valve Disease
Treatment
diagnostic flow
Clinical Study ID
NCT04916535
367/2021/Oss/AOUFe
Ages 18-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion criteria:
Subject aged ≥18 years and <65 years
Evidence of MAD during routine echocardiography clinically indicated by treatingphysician for any reason
Written informed consent
Exclusion
Exclusion criteria:
• Patient's refusal
Study Design
Total Participants: 249
Treatment Group(s): 1
Primary Treatment: diagnostic flow
Phase:
Study Start date:
June 03, 2021
Estimated Completion Date:
July 01, 2030
Study Description
Connect with a study center
Cardiology Unit
Bologna,
ItalySite Not Available
University Hospital of Ferrara
Ferrara, 44124
ItalySite Not Available
Morgagni Hospital
Forlì,
ItalySite Not Available
Cardiology Unit
Palermo,
ItalySite Not Available
Santa Maria delle Croci Hospital
Ravenna,
ItalySite Not Available
Cardiology Unit
Rimini,
ItalySite Not Available
University Hospital fo Trieste
Trieste,
ItalySite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.